A subsidiary of the UK based FTSE 100 Smiths Group plc, the company is a leading provider of medical devices for the hospital, emergency, home and specialist environments.

Smiths Medical, part of the global technology business Smiths Group, has received 510(k) clearance from the FDA for its CADD-Solis Ambulatory Infusion System, a next generation ambulatory infusion platform that enhances patient safety and personalized care for pain management patients.

Smiths Medical, ASD, Inc., a leader in high-quality medical devices and products, announced that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its Saf-T Closed Blood Collection System® for use in syringe blood draw and transfer applications.

Smiths Medical, part of the global technology business Smiths Group, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the P.A.S. PORT® T2 POWER P.A.C. and PORT-A-CATH® II POWER P.A.C. Dual-lumen Implantable Access Systems.

Smiths Medical, MD, Inc., part of the global technology business Smiths Group, proudly announces its award of accreditation status by the Accreditation Commission for Health Care, Inc. (ACHC) for medical supply services.